| scholarly article | Q13442814 |
| P2093 | author name string | Jay S Schneider | |
| Sarah K Kidd | |||
| P2860 | cites work | Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. | Q48235397 |
| Manganese superoxide dismutase overexpression attenuates MPTP toxicity. | Q48332030 | ||
| Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain | Q48431778 | ||
| Mechanisms of MPTP toxicity | Q48456918 | ||
| Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. | Q48806014 | ||
| Histochemical detection of apoptosis in Parkinson's disease. | Q67401850 | ||
| The many roles of histone deacetylases in development and physiology: implications for disease and therapy | Q24628821 | ||
| Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition | Q28468536 | ||
| Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen | Q29616224 | ||
| Oxidative stress in Parkinson's disease | Q29618017 | ||
| Recent advances in the discovery of small molecule histone deacetylase inhibitors. | Q34798850 | ||
| MPTP: insights into parkinsonian neurodegeneration | Q34802076 | ||
| Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway | Q34923735 | ||
| The role of glial reaction and inflammation in Parkinson's disease. | Q35171038 | ||
| In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining | Q36857701 | ||
| Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection | Q36959335 | ||
| Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons | Q36965800 | ||
| Therapeutic application of histone deacetylase inhibitors for central nervous system disorders | Q37283454 | ||
| Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity | Q37341162 | ||
| HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells | Q39786674 | ||
| Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells | Q40103666 | ||
| Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation | Q40152899 | ||
| Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. | Q40232814 | ||
| Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. | Q40323686 | ||
| n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells | Q40497185 | ||
| Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors. | Q45302980 | ||
| Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia. | Q46404080 | ||
| Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis | Q46805732 | ||
| Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat. | Q48154378 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 172-178 | |
| P577 | publication date | 2010-07-21 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition | |
| P478 | volume | 1354 |
| Q38766912 | A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease. |
| Q26766586 | Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? |
| Q48635091 | Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult |
| Q34243594 | Developmental exposure to the organochlorine insecticide endosulfan damages the nigrostriatal dopamine system in male offspring |
| Q27023811 | Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities |
| Q38379396 | Epigenetic mechanisms in neurological and neurodegenerative diseases |
| Q38881221 | Epigenetic regulation in Parkinson's disease |
| Q36693263 | Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: role of dopamine handling in neurotoxicity |
| Q90403568 | Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling |
| Q53375184 | Genetics and epigenetics of Parkinson's disease. |
| Q100694558 | Gut microbial molecules in behavioural and neurodegenerative conditions |
| Q90042859 | Histone acetylation in refractory sudden sensorineural hearing loss patients after intratympanic methylprednisolone perfusion |
| Q50656271 | Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice. |
| Q28483833 | Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A |
| Q39393210 | Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. |
| Q35978159 | Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors. |
| Q38962543 | Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome |
| Q58555658 | Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases |
| Q26744563 | Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity |
| Q91687777 | Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease |
| Q35385117 | Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease |
| Q36366275 | Selective damage to dopaminergic transporters following exposure to the brominated flame retardant, HBCDD |
| Q37040889 | Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease |
| Q64249465 | Systematic Review of Gut Microbiota and Major Depression |
| Q36613561 | Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell-derived dopaminergic neurons |
| Q38361065 | Targeting histone deacetylases: a novel approach in Parkinson's disease |
| Q38527233 | The epigenetics of aging and neurodegeneration. |
| Q24626017 | Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder |
| Q37737705 | Valproic Acid Protects Primary Dopamine Neurons from MPP+-Induced Neurotoxicity: Involvement of GSK3β Phosphorylation by Akt and ERK through the Mitochondrial Intrinsic Apoptotic Pathway |
| Q48351124 | Valproic acid-mediated inhibition of trimethyltin-induced deficits in memory and learning in the rat does not directly depend on its anti-oxidant properties. |
Search more.